Donor Screening for Human T‐Cell Lymphotrophic Virus 1/2: The future Is Uncertain

Screening of organ donors for HTLV‐1/2 infection has advantages and disadvantages that must be weighed, and rational decisions will require new evidence.
See minireview by Kaul et al on page 207.

Saved in:
Bibliographic Details
Published inAmerican journal of transplantation Vol. 10; no. 2; pp. 199 - 200
Main Author Humar, A.
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.02.2010
Subjects
HTLV-I Infections - diagnosis
Human T-lymphotropic virus 1 - isolation & purification
Humans
T-Lymphocytes
Online AccessGet full text

Cover

More Information
Summary:Screening of organ donors for HTLV‐1/2 infection has advantages and disadvantages that must be weighed, and rational decisions will require new evidence.
See minireview by Kaul et al on page 207.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1600-6135
1600-6143
DOI:10.1111/j.1600-6143.2009.02970.x